Get the Stockscreener App
13.72
1.86%
-0.26
After Hours:
13.62
-0.10
-0.73%
Tonix Pharmaceuticals Holding Corp stock is traded at $13.72, with a volume of 303.75K.
It is down -1.86% in the last 24 hours and down -8.23% over the past month.
Tonix Pharmaceuticals Holding Corp is a commercial-stage biotechnology company focused on the development and commercialization of treatments for central nervous system (CNS) disorders and immunological conditions. Its product portfolio includes TONMYA (cyclobenzaprine HCl sublingual tablets 2.8 mg), an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
See More
Previous Close:
$13.98
Open:
$13.9
24h Volume:
303.75K
Relative Volume:
0.70
Market Cap:
$175.45M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-1.2185
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
-4.92%
1M Performance:
-8.23%
6M Performance:
-48.30%
1Y Performance:
+25.18%
1-Day Range:
$13.46
$14.11
1-Week Range:
$13.16
$14.44
52-Week Range:
$10.80
$69.97
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Name
Tonix Pharmaceuticals Holding Corp
Sector
Industry
Phone
212-980-9155
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Compare TNXP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
13.72 | 178.78M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-18-22 | Initiated | Noble Capital Markets | Outperform |
| Apr-18-19 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-18-17 | Upgrade | ROTH Capital | Neutral → Buy |
| Sep-07-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-17-16 | Reiterated | Oppenheimer | Outperform |
| Nov-04-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-12-15 | Initiated | Oppenheimer | Outperform |
| Feb-17-15 | Reiterated | ROTH Capital | Buy |
| Sep-29-14 | Reiterated | ROTH Capital | Buy |
View All
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
TONMYA fibromyalgia tablet under tongue bypasses first-pass liver metabolism - Stock Titan
Tonix Pharmaceuticals Announces Publication of Clinical - GlobeNewswire
Tonix Pharmaceuticals: Tonmya launches for fibromyalgia as pipeline advances toward key 2027 milestones - TradingView
Tonix Pharmaceuticals to Present Poster on Tonmya at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting - Bitget
New fibromyalgia treatment Tonmya shows gains in patient outcomes poster - Stock Titan
Tonix Pharma Uplists to Nasdaq Global Select Market - TipRanks
Tonix Pharmaceuticals announces uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals Moves Listing to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals (TNXP) Moves to Nasdaq Global Select Marke - GuruFocus
Tonix Pharmaceuticals moves to Nasdaq Global Select Market - Investing.com
Tonix Pharmaceuticals approved to transfer listing to Nasdaq Global Select Market - TradingView
Tonix Pharmaceuticals (NASDAQ: TNXP) uplists to Nasdaq Global Select tier - Stock Titan
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - Yahoo Finance Singapore
Avoiding Lag: Real-Time Signals in (TNXP) Movement - Stock Traders Daily
Tonix Pharmaceuticals to Present Clinical Trial Data on Fibromyalgia Drug Tonmya at 2026 AAPM PainConnect Meeting - geneonline.com
Tonix Pharmaceuticals : March 2026 Investor Deck - marketscreener.com
Tonix Pharmaceuticals to Participate in Two Investor Conferences in March - Sahm
TNXP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tonix (TNXP) COO awarded two stock option grants under 2020 plan - Stock Titan
Tonix (TNXP) CFO granted stock options with multi-year vesting - Stock Titan
Tonix Pharmaceuticals (TNXP) CMO granted two new stock option awards - Stock Titan
Tonix Pharmaceuticals (TNXP) CTO receives two new stock option grants - Stock Titan
Tonix Pharmaceuticals (TNXP) CEO awarded new multi-year stock option grants - Stock Titan
TNXP Stock Price, Forecast & Analysis | TONIX PHARMACEUTICALS HOLDIN (NASDAQ:TNXP) - ChartMill
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences in March 2026 - Quiver Quantitative
Fibromyalgia drug maker Tonix to brief investors at March conferences - Stock Titan
Tonix Pharmaceuticals: Financial Runway and Pipeline Progress Under Scrutiny - AD HOC NEWS
Discipline and Rules-Based Execution in TNXP Response - Stock Traders Daily
Is Tonix Pharmaceuticals Holding Corp. forming a breakout pattern2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - mfd.ru
Aug Catalysts: Will Tonix Pharmaceuticals Holding Corp announce a stock split2025 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
What is the PEG ratio of Tonix Pharmaceuticals Holding Corp.2025 Volatility Report & Accurate Entry and Exit Point Alerts - mfd.ru
TNXP PE Ratio & Valuation, Is TNXP Overvalued - Intellectia AI
What are Tonix Pharmaceuticals Holding Corp.’s earnings expectationsSwing Trade & Community Trade Idea Sharing Platform - mfd.ru
TNXP News Today | Why did Tonix Pharmaceuticals stock go up today? - MarketBeat
Behavioral Patterns of TNXP and Institutional Flows - Stock Traders Daily
Market Recap: Will Tonix Pharmaceuticals Holding Corp stock benefit from M APortfolio Value Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Earnings Recap: Can Tonix Pharmaceuticals Holding Corp deliver alphaJuly 2025 Opening Moves & Verified Momentum Stock Ideas - baoquankhu1.vn
Dying for Some Sleep - RealClearHealth
Tonix Pharmaceuticals (TNXP) outlines preliminary 2025 figures and cash runway into 2027 - Stock Titan
Tonix opens Berkeley Heights HQ, expands NJ biotech footprint - NJBIZ
Aug Opening: How volatile is Haverty Furniture Companies Inc stockPortfolio Risk Report & Verified High Yield Trade Plans - baoquankhu1.vn
Tonix’s fibromyalgia drug shows significant pain reduction in study By Investing.com - Investing.com Australia
Tonix Highlights Significant Phase 3 RESILIENT Results For TONMYA At Non-Opioid Pain Summit - Nasdaq
Tonix Presents Positive Phase 3 RESILIENT Data On TONMYA At 2026 Non-Opioid Pain Therapeutics Summit - Nasdaq
Tonix Pharmaceuticals (TNXP) Reports Positive Phase 3 Trial Resu - GuruFocus
Tonix’s fibromyalgia drug shows significant pain reduction in study - Investing.com
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit - The Manila Times
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on - GlobeNewswire
Pharma company Tonix opening HQ in Berkeley Heights - ROI-NJ
Fibromyalgia Market: Expanding Revenue Landscape to 2034 – DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK, UCB Pharma - Barchart.com
(TNXP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):